Skip to main content
OpenTrials
Completed

NCT Number: NCT07068113

Effects of Turkish Traditional Dances on Postmenopausal Osteopenic Women

The aim of this study is to evaluate the effects of regular Turkish regional dances, in addition to conventional exercises given with a home program, on the quality of life, balance, aerobic capacity, bone mineral density (femoral neck, total and lumbar L1-4 and L2-4 T scores) and bone turnover markers (Type 1 collagen C-telopeptide [CTX-1] and Serum Procollagen 1 N-terminal peptide [P1NP]) of postmenopausal osteopenic women aged 50-60 years. Our study also aims to evaluate the compliance of patients to the exercise programs given to postmenopausal osteopenic women.

-What is the effect of regular Turkish regional dances on balance, aerobic capacity, muscle strength, quality of life, Bone Mineral Densitometry and Bone Turnover Markers in postmenopausal osteopenic women?

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ankara Etlik Ciy Hospital

Ankara, Yenimahalle, 060000, Turkey (Türkiye)

About this study

Patients who meet the criteria of our study will first be divided into 2 different groups by a closed envelope drawing method performed by a clinic secretary who is not involved in the study. Both groups will be asked to do a home exercise program 3-5 days a week. This home program will include the movements in the attached exercise sheets (Warm-up, Cool-down, Balance and Strengthening exercises, which were created from the sheets taken from https://theros.org.uk). It will be shown by the physiotherapist at the beginning of the study.

In addition to home exercises, participants in the first group will be asked to dance to dance videos from various regions, lasting 30 minutes, at a tempo determined by the study team before the study.

The dance videos will consist of rhythmic and tempo Turkish Regional Dances such as horon, Ankara Dance Tunes, and halay varieties. These videos have been uploaded to the ''Osteopeni folk dances'' YouTube channel and the links to these videos will be shared with the participants. (The videos will be closed to access during the study and only the video link owners will be able to access these videos. Links https://youtube.com/playlist?list=PLxRTiZv_4GGMtNYzIuGVsde6T_bzLt0V&si=W XRPO-GA1iWtGHuw, https://youtube.com/playlist?list=PLxRTiZv_4GGMVXcRx7uhntLdU4LtvmVC5&si =nvxk1VGbPia04xQF, https://youtube.com/playlist?list=PLxRTiZv_4GGMccS_iYDW3I_ ODCODEdTx&si=lD-7_fU1vWJ-ZQOn)

Before dancing, 10 minutes of warm-up, 30 minutes of dancing, and 10 minutes of cooling down exercises will be performed. It is planned that patients will dance at least 2 days a week for a minimum of 50 minutes. In addition, it is planned to reach a minimum of 150 minutes/week aerobic exercise target by having them walk briskly for at least 50 minutes once a week.

Participants in the 2nd group will not be prescribed dance, in addition to the home exercise program, they will be recommended to walk only 3 days a week, for a total of 150 minutes per week.

Participants in the 1st group will be given the FORM-1, and participants in the 2nd group will be given the FORM-2, and they will be asked to fill out these forms daily. The form-1 in will ask for the duration of the home exercises or Turkish folk dances that were performed that day. The form in FORM-2 will also ask for the duration of the home exercises that were performed that day. Both groups will also be given the FORM-3, and they will be asked to write down the complications that occurred during the daily exercise.

Only the study group (1st group) will be called monthly and issues such as whether the forms are filled out daily and compliance with the exercises will be discussed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being a postmenopausal woman between the ages of 50-60
  • Not having a known diagnosis of osteoporosis and not having taken any antiresorptive or anabolic agents before
  • Being diagnosed with osteopenia with DEXA taken in the last 6 months at Etlik City Hospital (femoral neck, femoral total L1-4 or L2-4 T score between -1 and -2.5)
  • Being literate
  • Having a 25-Hydroxy vitamin D level in the blood >20 µg/L
  • Having a phone that can be used for communication for oneself or one of the family members, as well as having a smart phone, tablet or computer that can be used to watch videos
  • Being willing to participate in the study

Exclusion criteria

  • Having a body mass index >30 kg/m2
  • Having an extremely sedentary lifestyle (International Physical Activity Scale-Inactive according to Short Form)
  • Presence of fragility fracture
  • Presence of malignancy
  • Presence of cardiovascular or respiratory system disease that will prevent exercise (unstable angina, uncontrolled atrial or ventricular arrhythmia, 3rd degree atrioventricular block, severe aortic stenosis, severe asthma-COPD)
  • Presence of current neurological disease that will prevent exercise (CVA, MS)
  • Presence of psychiatric disease that will prevent exercise or cause non-compliance in follow-ups
  • Presence of musculoskeletal system disease that will prevent exercise (Stage 3-4 osteoarthritis, severe spinal stenosis, severe radiculopathy, lumbar surgery within the last 1 year)
  • Presence of known inflammatory joint disease
  • Presence of advanced vision, hearing loss or vertigo etc. that will prevent the patient from doing exercises or regional dances. Having any disease that will disrupt harmony by causing balance problems
  • Using active estrogen or progesterone containing preparations
  • Presence of hyperthyroidism

Treatment and study plan

DANCE GROUP

Other

home exercise program + 50 min/week brisk walking + 100 min/week dance

Exercise group

Other

home exercise program + 150 min/week brisk walking

Primary outcomes

  1. Bone Turnover Markers(Type 1 collagen C-telopeptide)

    Time frame: three month

    Serum Type 1 collagen C-telopeptide (CTX-1) will be used for bone resorption.

  2. Bone Turnover Markers(Serum Procollagen 1 N-terminal peptide)

    Time frame: three month

    Serum Procollagen 1 N-terminal peptide (P1NP) will be used for bone formation

  3. Bone Mineral Density(Femoral Neck T scores)

    Time frame: six month

    In our study, femoral neck T scores bone mineral densities in g/cm2 will be noted with Dual-energy X-ray absorptiometry .Values obtained by bone mineral density (BMD) measurement are divided into diagnostic classification by the World Health Organization (WHO) as normal bone mass, low bone mass (osteopenia) and osteoporosis. Normal bone mass is above -1 standard deviation point relative to the mean bone mineral density of the young adult reference population (T score -1 and above). Osteopenia (low bone mass) is when the bone mineral density is below -1 standard deviation score and above -2.5 standard deviation points compared to the average bone mineral density of the young adult reference population (T score between -1 and -2.5). Osteoporosis is defined as bone mineral density below -2.5 standard deviation points compared to the average of the young adult reference population (T score below -2.5 points).

  4. Bone Mineral Density(Femoral total T scores)

    Time frame: six month

    In our study, femoral total T scores and bone mineral densities in g/cm2 will be noted with Dual-energy X-ray absorptiometry.Values obtained by bone mineral density (BMD) measurement are divided into diagnostic classification by the World Health Organization (WHO) as normal bone mass, low bone mass (osteopenia) and osteoporosis. Normal bone mass is above -1 standard deviation point relative to the mean bone mineral density of the young adult reference population (T score -1 and above). Osteopenia (low bone mass) is when the bone mineral density is below -1 standard deviation score and above -2.5 standard deviation points compared to the average bone mineral density of the young adult reference population (T score between -1 and -2.5). Osteoporosis is defined as bone mineral density below -2.5 standard deviation points compared to the average of the young adult reference population (T score below -2.5 points).

  5. bone mineral density(lumbar 1-4 Tscores)

    Time frame: six month

    In our study, lumbar 1-4 T scores bone mineral densities in g/cm2 will be noted with Dual-energy X-ray absorptiometry .Values obtained by bone mineral density (BMD) measurement are divided into diagnostic classification by the World Health Organization (WHO) as normal bone mass, low bone mass (osteopenia) and osteoporosis. Normal bone mass is above -1 standard deviation point relative to the mean bone mineral density of the young adult reference population (T score -1 and above). Osteopenia (low bone mass) is when the bone mineral density is below -1 standard deviation score and above -2.5 standard deviation points compared to the average bone mineral density of the young adult reference population (T score between -1 and -2.5). Osteoporosis is defined as bone mineral density below -2.5 standard deviation points compared to the average of the young adult reference population (T score below -2.5 points).

  6. bone mineral density(lumbar 2-4 T scores)

    Time frame: six month

    In our study, lumbar 2-4 T scores bone mineral densities in g/cm2 will be noted with Dual-energy X-ray absorptiometry .Values obtained by bone mineral density (BMD) measurement are divided into diagnostic classification by the World Health Organization (WHO) as normal bone mass, low bone mass (osteopenia) and osteoporosis. Normal bone mass is above -1 standard deviation point relative to the mean bone mineral density of the young adult reference population (T score -1 and above). Osteopenia (low bone mass) is when the bone mineral density is below -1 standard deviation score and above -2.5 standard deviation points compared to the average bone mineral density of the young adult reference population (T score between -1 and -2.5). Osteoporosis is defined as bone mineral density below -2.5 standard deviation points compared to the average of the young adult reference population (T score below -2.5 points).

Secondary outcomes

  1. BALANCE

    Time frame: three month

    Static and balance indicators will be checked with Tecnobody PK 252 isokinetic balance measurement system and additionally functional reach test will be noted.

  2. muscle strength

    Time frame: three month

    Quadriceps muscle strength of the dominant side will be checked with the Lafayette device.

  3. aerobic capacity

    Time frame: three month

    Aerobic capacity will be measured with a 6-minute walk test

  4. quality of life measurement

    Time frame: three month

    Quality of life will be measured with the Quality Of Life Questionnaire of the European Foundation for Osteoporosis-41 (QUALEFFO-41) Scale.

    QUALEFFO-41 consists of 5 subscales examining the five dimensions of health, such as pain (5 items), physical function (17 items), social function (7 items), general health assessment (3 items) and mental function (9 items). Validity and reliability for Turkish was done by Koçyiğit and his colleagues.

    The answers to the questions in the QUALEFFO-41 scale are scored from 1 (healthy) to 5 (unhealthy) in the order of options. The section score and total score are calculated by transferring the scores to a measurement out of 100. For each subgroup and total result in the scale, a score of 0 indicates the best health status, while a score of 100 indicates the worst health status

Sponsors and collaborators

Lead sponsor

Ankara Etlik City Hospital

Other Gov

Registry information

Official study title

Effects of Turkish Traditional Dances on Bone Mineral Density, Bone Turnover Markers, Balance, Aerobic Capacity and Quality of Life in Postmenopausal Osteopenic Women

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 16, 2025
Registry last updated
Mar 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.